Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
about
Antiviral restriction factor transgenesis in the domestic catPharmacological inhibition of feline immunodeficiency virus (FIV)Recent developments in human immunodeficiency virus-1 latency researchSelective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesStrain-specific viral distribution and neuropathology of feline immunodeficiency virusGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsProductive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector developmentPreferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factorsThe role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progressionExpanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cellsMultiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.In vivo monocyte tropism of pathogenic feline immunodeficiency virusesBinding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociaPathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements.Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.Early pathogenesis of transmucosal feline immunodeficiency virus infection.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblastsC-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection.Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptorExperimental mucosal infection with molecularly cloned feline immunodeficiency virusesLentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibilityAIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogensIdentification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection.Feline immunodeficiency virus (FIV) neutralization: a reviewFeline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.Multiple restrictions of human immunodeficiency virus type 1 in feline cells.Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligandPeptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor.Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infectionsMapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
P2860
Q24567554-6556F3E2-4ACA-4466-A174-B33B30AF0A3CQ26995310-DF16E420-2821-4E58-B19F-5365F295B78CQ27013114-E0386A99-5757-4311-9094-96A118A169EEQ27318192-3B684048-6B2A-489E-B37D-BBF0238DB99AQ30462523-378825C8-C695-4BF9-B831-EAF522FD17C4Q31066870-9A8D4426-CAAF-45F6-90BF-3A044F8B694DQ33587317-F32009B5-DB9D-4061-9F1E-B43F2720FE4FQ33647409-582A5732-9BEB-4999-ACA3-80DB9665B086Q33654133-10E22407-7EC7-436A-8928-8EC78F8A8107Q33724212-59EBEF61-4221-4250-BF18-332D1596EF8CQ33785345-5A05B8A4-BA02-4EF9-B8F2-B0C91E9CA664Q33797700-FE32814F-3D05-4E7B-9181-E9D57559D6DCQ33804363-E46ACB3E-0C33-474B-9E33-54DE40E71B55Q33817827-1EDC032B-E6FA-4230-8F9B-B96EB24D1275Q33840312-CE2F38C0-E89F-4BCF-A1A8-DC9885B665C5Q33981547-C5EF1B95-C9B4-414E-BFA4-CD778A7739FEQ34009788-3F07EA87-FF37-4BBC-8736-FDC97BA485F4Q34010373-469A7FFF-082A-4BE5-B1A2-852403445160Q34335096-6600AE09-6C3A-442E-AA87-04114ACC3F40Q34339634-9AD4181A-B9E1-4A0A-B1B0-60DC4ED7151EQ34339913-811949B9-182D-4D4B-ACD9-5FAA2CEF47E5Q34342119-C6FCA917-1A7C-45D3-940A-6094796E222BQ34345536-1A0210A6-4192-42F6-A467-14293331266DQ34461442-455AD2B8-0225-4B27-8A8E-5225C679254FQ34545719-6436BBFD-4D46-4B08-A0F6-FB832E26D1D8Q34550397-2BF36B9A-3ADB-4C30-9E43-6749B31AD3F0Q34579743-5B5F4C4A-974F-48F1-972B-4B864EDE0772Q34755001-20899FBE-9BD5-4E5C-AA74-EBDBC7490B5FQ35024266-D5974932-37E1-4A2D-8DC1-AFDD268F87EEQ35077801-2C0B766D-E1D4-4F83-976F-98A98264EC7AQ35149650-1FC715D9-BA23-49CA-9B2B-7732CC2B4D5CQ35491705-E5875FB9-07D8-4AE6-B1F3-219D20AA90F8Q35531590-941BB023-77C3-4BA1-9338-90A8691069E9Q35914370-FA98A4B7-05B5-4F26-9A16-9798CE4CB48FQ36098854-BA1A5468-79B6-4A6B-BC45-4A5E11C3F3D4Q36138326-3656550A-77A5-4FCA-82EC-989E0BFA6103Q36397999-C4A7171B-AA19-426D-879F-213D301F2D00Q36470890-CCFB4731-5FB6-471B-9DE9-EA14CC2712DEQ36699711-4EBAF9E5-A20C-471E-AB35-307EB34822C3Q36831291-71EC1529-4C8F-4735-9954-19EDE12E7E6C
P2860
Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@ast
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@en
type
label
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@ast
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@en
prefLabel
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@ast
Shared usage of the chemokine ...... uman immunodeficiency viruses.
@en
P2093
P2860
P1433
P1476
Shared usage of the chemokine ...... human immunodeficiency viruses
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z